They identified and verified a limited proteomic feature that can distinguish VAP(+) from VAP(−) patients, which is composed of the following three proteins: S100A8, Lactoferrin (LTF) and Actin 1 (ACTN1). This evidence concerns the gene LTF and ventilator-associated pneumonia.